2013 Apr 15 Annual Report 2012 - Phosphagenics

More documents

Recommendations

Info

Consolidated statement of cash fl ow FOR THE YEAR ENDED 31 DECEMBER 2012 Note OPERATING ACTIVITIES 2012 $’000 2011 $’000 Receipts from customers 1,956 2,439 Receipt of government grants 27 105 Payments to suppliers and employees (13,646) (11,837) Net cash used in operating activities 20(b) (11,663) (9,293) INVESTING ACTIVITIES Interest received 1,248 216 Proceeds from available-for-sale investments - 971 Purchase of plant and equipment (184) (79) Net cash from investing activities 1,064 1,108 FINANCING ACTIVITIES Proceeds from issues of shares 13 356 34,707 Costs of issue of shares (41) (2,066) Net cash from financing activities 315 32,641 66 Net increase/(decrease) in cash and cash equivalents (10,284) 24,456 Cash and cash equivalents at the beginning of period 27,196 2,740 CASH AND CASH EQUIVALENTS AT THE END OF PERIOD 20(a) 16,912 27,196 The above Statement of cash fl ows should be read in conjunction with the accompanying notes. PHOSPHAGENICS ANNUAL REPORT 2012
Consolidated statement of changes in equity Issued Capital $’000 Employee Benefits Reserve $’000 Other Benefits Reserve $’000 Business Combination & Foreign Currency Translation Reserve $’000 Accumulated Losses $’000 Total $’000 Balance at 1 January 2012 209,546 1,193 306 27,819 (165,918) 72,946 Profi t / (loss) for the period - - - - (11,055) (11,055) Other comprehensive income - - - 11 - 11 Total comprehensive income for the period - - - 11 (11,055) (11,044) Transactions with owners in their capacity as owners: Issue of share capital 356 356 Transaction costs (41) (41) Employee equity settlement benefi ts - 395 - - - 395 Share based payments - - - - - - Balance at 31 December 2012 209,861 1,588 306 27,830 (176,973) 62,612 67 Balance at 1 January 2011 176,905 1,057 248 27,821 (167,024) 39,007 Loss for the period - - - - 1,106 1,106 Other comprehensive income - - - (2) - (2) Total comprehensive income for the period - - - (2) 1,106 1,104 Transactions with owners in their capacity as owners: Issue of share capital 34,707 34,707 Transaction costs (2,066) (2,066) Employee equity settlement benefi ts - 136 - - - 136 Share based payments - - 58 - - 58 Balance at 31 December 2011 209,546 1,193 306 27,819 (165,918) 72,946 The above Statement of changes in equity should be read in conjunction with the accompanying notes. CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
Page 1 and 2:
20 12 Annual Report PHOSPHAGENICS P
Page 3 and 4:
highlights March... April... May...
Page 5 and 6:
03 Jonathan Addison Chairman & Inde
Page 7 and 8:
COLLABORATIONS Strategic Collaborat
Page 9 and 10:
The Phosphagenics Evolution THE STO
Page 11 and 12:
“ We also reached agreement with
Page 13 and 14:
Overview of our opioid development
Page 15 and 16:
13 is branded as Butrans or Norspan
Page 17 and 18: Personal Care ASHLAND INC (FORMERLY
Page 19 and 20: BEAUTY IS MORE THAN SKIN DEEP 17 EL
Page 21 and 22: cellulite contour crème BioElixia
Page 23 and 24: Intellectual Property Title Countri
Page 25 and 26: 2009 2008 2007 2006 6.8 7.8 22.2 23
Page 27 and 28: DR ESRA OGRU (AGED 37 YEARS) BSC (H
Page 29 and 30: Senior Management DR PAUL GAVIN Chi
Page 31 and 32: Phosphagenics Limited ABN 32 056 48
Page 33 and 34: Directors’ Report Your directors
Page 35 and 36: Directors’ Report continued Looki
Page 37 and 38: Directors’ Report continued Commi
Page 39 and 40: Directors’ Report continued REMUN
Page 43 and 44: Directors’ Report continued Share
Page 45 and 46: Directors’ Report continued Share
Page 47 and 48: Exercise Price Expiry Date Net othe
Page 49 and 50: Exercise Price Expiry Date Net othe
Page 51 and 52: Fair value per performance right at
Page 55 and 56: Auditors Independence Declaration 5
Page 57 and 58: Corporate Governance Statement cont
Page 67: Consolidated statement of fi nancia
Page 71 and 72: Notes to the consolidated fi nancia
Page 73 and 74: Application date of standard Impact
Page 113 and 114: Independent Auditor’s Report 111
Page 115 and 116: Additional Shareholder Information
Page 117 and 118: Additional Shareholder Information
Page 119:
corporate directory Phosphagenics L
show all

2013 Apr 15 Annual Report 2012 - Phosphagenics

Create successful ePaper yourself

Delete template?

Save as template?